Dr Marc

Biography

DR Marc is the CEO and co-founder of Antabio and a member of the Board of the European Alliance of Biopharmaceutical companies combating Anti-Microbial resistance (BEAM Alliance). A molecular microbiologist by training, Marc is the author of numerous peer-reviewed articles in the field of pathogenic bacterial infections and their biology. Prior to founding Antabio, Marc held different research positions at various institutions globally such as CNRS and Inserm (France), CSIC (Spain) and Emory University (USA). At Antabio, Marc structured the corporate and financial aspects of the company and successfully managed Antabio’s fundraisings using different strategies including innovative tools such as crowdfunding (Antabio being the world-premier crowdfunding exit for a biotech start-up). Under Marc’s leadership, ANTABIO has attracted low double-digit million funding and received numerous awards including the BIOVISION Investment Conference Award (2016), the “Concours Mondial de l’Innovation” Worldwide Innovation Challenge (2014), and two Seeding Drug Discovery Awards from the Wellcome Trust(2013 and 2015).

Research Interest

Dr Marc is the CEO and co-founder of Antabio and a member of the Board of the European Alliance of Biopharmaceutical companies combating Anti-Microbial resistance (BEAM Alliance). A molecular microbiologist by training, Marc is the author of numerous peer-reviewed articles in the field of pathogenic bacterial infections and their biology. Prior to founding Antabio, Marc held different research positions at various institutions globally such as CNRS and Inserm (France), CSIC (Spain) and Emory University (USA). At Antabio, Marc structured the corporate and financial aspects of the company and successfully managed Antabio’s fundraisings using different strategies including innovative tools such as crowdfunding (Antabio being the world-premier crowdfunding exit for a biotech start-up). Under Marc’s leadership, ANTABIO has attracted low double-digit million funding and received numerous awards including the BIOVISION Investment Conference Award (2016), the “Concours Mondial de l’Innovation” Worldwide Innovation Challenge (2014), and two Seeding Drug Discovery Awards from the Wellcome Trust(2013 and 2015).